High blood sugar levels in diabetics produce more enzymes called MAPK kinases, leading to early brain cell death. Hebrew University of Jerusalem researchers have developed a peptide TXM-CB3 that in laboratory tests prevents the MAPK kinases from activating.
http://www.eurekalert.org/pub_releases/2014-01/thuo-nmp012814.php